Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

RELIEF THERAPEUTICS HOLDING AG

(RLF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Relief Therapeutics Partner NRx Receives US FDA's Emergency Use Rejection For Aviptadil

07/04/2022 | 01:26am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
NRX PHARMACEUTICALS, INC. 0.71% 0.7252 Delayed Quote.-84.83%
RELIEF THERAPEUTICS HOLDING AG -3.35% 0.026 Delayed Quote.-56.75%
All news about RELIEF THERAPEUTICS HOLDING AG
09/22Relief Therapeutics Gets US Approval to Launch Pilot Trial For Skin Disease Treatment
MT
09/22Relief Therapeutics Holding AG Announces IRB Approval and Initiation of an Investigator..
CI
09/22Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated ..
EQ
09/15Relief Therapeutics Holding AG Reports Earnings Results for the Half Year Ended June 30..
CI
09/15Relief Therapeutics Posts Wider Attributable Loss In H1
MT
09/15Relief Reports Half-Year 2022 Results and Provides Corporate Update
EQ
09/12Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum
EQ
09/07Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment..
EQ
08/24Switzerland's Relief Therapeutics Seeks To List American Depositary Shares On NASDAQ
MT
08/24Relief Therapeutics files registration statement on form F-1 with the U.S. Securities a..
EQ
More news
Financials
Sales 2021 3,32  3,39  3,39 
Net income 2021 -34,7 M -35,4 M -35,4 M
Net cash 2021 40,5 M 41,3 M 41,3 M
P/E ratio 2021 -6,44x
Yield 2021 -
Capitalization 109 M 111 M 111 M
EV / Sales 2020 -
EV / Sales 2021 70 411 988x
Nbr of Employees 10
Free-Float 60,3%
Chart RELIEF THERAPEUTICS HOLDING AG
Duration : Period :
Relief Therapeutics Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RELIEF THERAPEUTICS HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 0,03
Average target price
Spread / Average Target -
Managers and Directors
Jack M. Weinstein Chief Financial Officer & Treasurer
Raghuram Selvaraju Chairman
Nermeen Varawalla Chief Medical Officer
Taneli Jouhikainen Chief Operating Officer
Thomas Plitz Director
Sector and Competitors
1st jan.Capi. (M$)
RELIEF THERAPEUTICS HOLDING AG-56.75%115
MODERNA, INC.-53.51%47 785
LONZA GROUP AG-37.97%35 765
IQVIA HOLDINGS INC.-35.63%34 633
SEAGEN INC.-12.23%25 400
ALNYLAM PHARMACEUTICALS, INC.24.28%25 297